paroxetine has been researched along with folic acid in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (66.67) | 24.3611 |
2020's | 3 (33.33) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Dou, M; Gong, A; Liang, H; Wan, D; Wang, Q; Yan, L; Yu, Z; Zhang, H | 1 |
Alexander, R; Carboni, L; Delafont, B; Domenici, E; Ivanchenko, E; Learned, SM; Ratti, E | 1 |
Aghajani, R; Arbabian, M; Drevet, JR; Gharagozloo, P; Nasr-Esfahani, MH; Razi, M; Sadeghi, N; Tavalaee, M | 1 |
1 review(s) available for paroxetine and folic acid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for paroxetine and folic acid
Article | Year |
---|---|
Folate metabolism biomarkers from two randomised placebo-controlled clinical studies with paroxetine and venlafaxine.
Topics: Biomarkers; Depressive Disorder, Major; Folic Acid; Humans; Paroxetine; Venlafaxine Hydrochloride | 2021 |
7 other study(ies) available for paroxetine and folic acid
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Joint replenishment of zinc and folic acid enhances the anti-depressive effect of paroxetine via increasing serum calcium and copper and decreasing serum arsenic.
Topics: Animals; Antidepressive Agents; Arsenic; Behavior, Animal; Bone and Bones; Calcium; Copper; Folic Acid; Male; Motor Activity; Paroxetine; Rats; Rats, Sprague-Dawley; Zinc | 2020 |
Paroxetine treatment in an animal model of depression improves sperm quality.
Topics: Animals; Folic Acid; Male; Mammals; Mice; Models, Animal; Paroxetine; Semen; Spermatozoa; Vitamin B 12 | 2022 |